JP2018515530A - 上気道感染症の予防および／または治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））のエンドウマメデンプン製剤 - Google Patents

上気道感染症の予防および／または治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））のエンドウマメデンプン製剤 Download PDF

Info

Publication number
JP2018515530A
JP2018515530A JP2017559086A JP2017559086A JP2018515530A JP 2018515530 A JP2018515530 A JP 2018515530A JP 2017559086 A JP2017559086 A JP 2017559086A JP 2017559086 A JP2017559086 A JP 2017559086A JP 2018515530 A JP2018515530 A JP 2018515530A
Authority
JP
Japan
Prior art keywords
composition
starch
microparticles
polyinosinic
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017559086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515530A5 (enExample
Inventor
ディエック，アレックス，エンリ バン
ディエック，アレックス，エンリ バン
メンシュ，ユルゲン
Original Assignee
ヤンセン・サイエンシズ・アイルランド・ユーシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン・サイエンシズ・アイルランド・ユーシー filed Critical ヤンセン・サイエンシズ・アイルランド・ユーシー
Publication of JP2018515530A publication Critical patent/JP2018515530A/ja
Publication of JP2018515530A5 publication Critical patent/JP2018515530A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2017559086A 2015-05-11 2016-05-10 上気道感染症の予防および／または治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））のエンドウマメデンプン製剤 Pending JP2018515530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15167129.4 2015-05-11
EP15167129 2015-05-11
PCT/IB2016/000890 WO2016181226A1 (en) 2015-05-11 2016-05-10 Polyinosinic-polycytidylic acid (poly(i:c)) pea starch formulation for the prevention and/or treatment of upper respiratory tract infections

Publications (2)

Publication Number Publication Date
JP2018515530A true JP2018515530A (ja) 2018-06-14
JP2018515530A5 JP2018515530A5 (enExample) 2019-06-13

Family

ID=53174864

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017559086A Pending JP2018515530A (ja) 2015-05-11 2016-05-10 上気道感染症の予防および／または治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））のエンドウマメデンプン製剤

Country Status (12)

Country Link
US (1) US20180353533A1 (enExample)
EP (1) EP3294268A1 (enExample)
JP (1) JP2018515530A (enExample)
KR (1) KR20180004233A (enExample)
CN (1) CN107820423A (enExample)
AU (1) AU2016259869A1 (enExample)
CA (1) CA2983659A1 (enExample)
HK (1) HK1251926A1 (enExample)
MA (1) MA44384A (enExample)
RU (1) RU2017142710A (enExample)
TW (1) TW201705963A (enExample)
WO (1) WO2016181226A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024500731A (ja) * 2020-12-23 2024-01-10 セントロ デ インジエニエリア ジエネテイカ イ バイオテクノロジア ウイルス起源の各感染症の治療のためのペプチド

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
KR102451861B1 (ko) 2021-03-09 2022-10-07 주식회사 오라팜 급성 호흡기 바이러스 및 로타바이러스 감염 질환 예방 및 치료를 위한 조성물
KR102439760B1 (ko) 2021-03-09 2022-09-02 주식회사 오라팜 상기도 감염균 질환 예방 및 치료를 위한 조성물
CN114917242A (zh) * 2022-05-31 2022-08-19 复旦大学附属中山医院 合成双链rna类似物经滴鼻预防呼吸道传播病毒的应用及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006312629A (ja) * 2005-05-05 2006-11-16 Natl Starch & Chem Investment Holding Corp 活性剤の送達に有用な組成物
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
WO2013164380A1 (en) * 2012-05-03 2013-11-07 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
JP6629216B2 (ja) * 2013-11-06 2020-01-15 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 上気道感染症の治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
JP2009209086A (ja) * 2008-03-04 2009-09-17 Masami Moriyama 粘膜投与型ワクチン
CN102988303A (zh) * 2011-09-15 2013-03-27 天津泽世德生物医药有限公司 一种多聚肌苷酸多聚胞苷酸冻干粉针的制备方法
TWI643082B (zh) * 2013-09-03 2018-12-01 美商新思科技股份有限公司 一種佈線出一解決路徑之方法及系統

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006312629A (ja) * 2005-05-05 2006-11-16 Natl Starch & Chem Investment Holding Corp 活性剤の送達に有用な組成物
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
WO2013164380A1 (en) * 2012-05-03 2013-11-07 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
JP6629216B2 (ja) * 2013-11-06 2020-01-15 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 上気道感染症の治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））製剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024500731A (ja) * 2020-12-23 2024-01-10 セントロ デ インジエニエリア ジエネテイカ イ バイオテクノロジア ウイルス起源の各感染症の治療のためのペプチド

Also Published As

Publication number Publication date
MA44384A (fr) 2019-01-23
KR20180004233A (ko) 2018-01-10
HK1251926A1 (zh) 2019-05-03
US20180353533A1 (en) 2018-12-13
WO2016181226A1 (en) 2016-11-17
CN107820423A (zh) 2018-03-20
CA2983659A1 (en) 2016-11-17
EP3294268A1 (en) 2018-03-21
TW201705963A (zh) 2017-02-16
RU2017142710A (ru) 2019-06-11
AU2016259869A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
US9987300B2 (en) Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
JP6629216B2 (ja) 上気道感染症の治療のためのポリイノシン酸−ポリシチジル酸（ポリ（ｉ：ｃ））製剤
US20180353533A1 (en) Polyinosinic-polycytidylic acid (poly (i:c)) pea starch formulation for the prevention and/or treatment of upper respiratory tract infections
US20200060972A1 (en) Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
CN121712513A (zh) 包含黄原胶或褐藻多糖的用于抗流感病毒的组合物
US20220031642A1 (en) Niclosamide Formulations and Methods of Use
HK1228749A1 (en) Polyinosinic-polycytidylic acid (poly (i:c) formulations for the treatment of upper respiratory tract infections
HK1203390B (en) Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections
CN116763746A (zh) 一种布瑞哌唑口崩片及其制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190509

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200609

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210105